ArticleWorld journal of urology2025
Silicone double-j stents for long-term ureteral stenting: results from a multicentric PEARLS analysis.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The role of triple double-J stents in managing uretero-ileal anastomotic strictures following urinary diversion.World journal of urology · 2026Observational
- Present and future of ureteral stent technology: a review by the EAU endourology section.World journal of urology · 2026Review
- Empowerment-Based Continuity of Care for Postoperative Upper Urinary Tract Calculi Patients with Double-J Stents: Effects on Self-Care and Compliance.Patient preference and adherence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeTo analyze outcomes from long-term ureteral stenting using silicone double-j stents (maximal dwell time of 12 months).
methodsPatients undergoing first-time insertion of an ImaJin™ or ImaJin Hydro™ silicone double-j stent with a planned dwell time of a least 3 months were considered. Patients treated between 2018 and 2024 were included in this multicenter, retrospective study. Primary endpoint was stent failure, defined as unplanned premature re-intervention.
results105 patients were available for analysis. Median age was 63 years. All stents were inserted using a hydrophilic guidewire without any complications related to stent insertion. In 11 patients (10%) the cause of ureteral obstruction was extrinsic, in 31 patients (30%) parietal and in 63 patients (60%) intra-luminal. Stent failure-free survival estimates at 1,3,6,9 and 12 months were 99%,98%,88%,82% and 69%, respectively. Estimated mean failure-free survival was 307 days (95% confidence interval 282 to 332). Among all baseline and perioperative parameters, increasing patient weight, increasing urinary leucocytes, and urinary tract infection (UTI) were found to be significant and independent predictors of stent failure (all p < 0.05). Spontaneous stent migration was noted in one patient (< 1%). Stent encrustation was documented in 13 patients (12%), with five of these cases occurring after > 365 days.
conclusionLong-term ureteral stenting with silicone double-j stents seems to be an effective and safe treatment with low encrustation and stent migration rates. Close follow-up and screening for stent failure shall be considered in patients with high weight, high urinary leucocytes or in cases with suspected UTI.
Indexed as
Identifiers
40353884What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.